抗體-藥物結合物(ADC)由理想的單克隆抗體、活性細胞毒性藥物和合適的連接劑組成??贵w和細胞毒性藥物之間的適當連接物提供特異性橋,從而幫助抗體選擇性地將細胞毒性藥物遞送至腫瘤細胞,并在腫瘤部位精確地釋放細胞毒性藥物
-
默認
常備現(xiàn)貨
-
純度
- 請選擇
- 99+%
- 99%
- 98+%
- 98%
- 97+%
- 97%
- 96+%
- 96%
- 95+%
- 95%
- 93%
- 90+%
- 90%
規(guī)格
- 請選擇
- 1mg
- 2mg
- 5mg
- 10mg
- 25mg
- 50mg
- 100mg
- 250mg
- 1g
- 5g
- 10g
- 25g
- 100g
- 500g
- 1000g
- 1kg
清空選項
-
1-Phenyl-2,5,8,11,14,17-hexaoxanonadecan-19-ol
-
BD26235724342-68-598%
-
¥45.00250mg常備現(xiàn)貨
-
1-Phenyl-2,5,8,11,14,17,20-heptaoxadocosan-22-ol
-
BD262358423763-19-397%
-
¥375.001g常備現(xiàn)貨
-
1-Phenyl-2,5,8,11,14,17,20,23-octaoxapentacosan-25-ol
-
BD262359477775-73-895%
-
¥245.001g常備現(xiàn)貨
-
1-Phenyl-2,5,8,11,14,17,20,23,26-nonaoxaoctacosan-28-ol
-
BD262360868594-48-398%
-
¥905.001g常備現(xiàn)貨
-
1-Phenyl-2,5,8,11,14,17,20,23,26,29-decaoxahentriacontan-31-ol
-
BD262361908258-44-698%
-
¥4648.001g常備現(xiàn)貨
-
2,5,8,11,14,17,20,23,26,29-Decaoxahentriacontan-31-ol
-
BD26236427425-92-995%
-
¥225.001g常備現(xiàn)貨
-
1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-oxo-7,10,13,16,19,22,25,28-octaoxa-4-azahentriacontan-31-oic acid
-
BD2827021334177-86-495%
-
¥1020.001g常備現(xiàn)貨
-
1-(17-Hydroxy-3,6,9,12,15-pentaoxaheptadecyl)-1H-pyrrole-2,5-dione
-
BD6897431584544-42-297%
-
¥6645.001g常備現(xiàn)貨
-
2,5-Dioxopyrrolidin-1-yl 1-chloro-2-oxo-6,9,12,15-tetraoxa-3-azaoctadecan-18-oate
-
BD3215931353011-95-695%
-
¥2731.001g常備現(xiàn)貨
-
3,6,9,12,15-Pentaoxatricosan-1-ol
-
BD14535219327-40-395%
-
¥537.001g常備現(xiàn)貨
-
3,6,9,12,15,18,21,24-Octaoxahexacosane-1,26-diol
-
BD1453923386-18-395%
-
¥259.005g常備現(xiàn)貨
-
3,6,9,12,15,18,21-Heptaoxatricosane-1,23-diol
-
BD1460215117-19-197%
-
¥315.0010g常備現(xiàn)貨
-
Pentaethylene glycol di-p-toluenesulfonate
-
BD14694041024-91-398%
-
¥968.0025g常備現(xiàn)貨
-
2-(2-(2-(2-Hydroxyethoxy)ethoxy)ethoxy)ethyl acrylate
-
BD62820019812-60-397% (stabilized with MeHQ)
-
¥2828.001g常備現(xiàn)貨
-
5,8,11-Trioxa-2-azatridecan-13-ol
-
BD66660690430-59-497%
-
¥380.001g常備現(xiàn)貨
-
Poly(ethylene glycol) dimethyl ether Mn 250
-
BD0142137124991-55-7average Mn 250
-
¥36.0025g常備現(xiàn)貨
-
2,5,8,11-Tetraoxatridecane-13-thiol
-
BD6730852190-55-395%
-
¥2474.001g常備現(xiàn)貨
-
3,6,9,12,15,18,21,24-Octaoxahexatriacontan-1-ol
-
BD1194433055-98-998%
-
¥3042.001g常備現(xiàn)貨
-
13-Azido-2,5,8,11-tetraoxatridecane
-
BD306351606130-90-995%
-
¥2273.001g常備現(xiàn)貨
-
2-(2-(2-(2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethoxy)ethoxy)ethanol dihydrochloride
-
BD2878641825392-15-197%
-
¥769.00250mg常備現(xiàn)貨
-
2,5-Dioxopyrrolidin-1-yl 3-(2-(2-(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanamido)ethoxy)ethoxy)propanoate
-
BD268025955094-26-595%
-
¥313.00250mg常備現(xiàn)貨
-
Sodium 1-((4-((2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)methyl)cyclohexane-1-carbonyl)oxy)-2,5-dioxopyrrolidine-3-sulfonate
-
BD26811892921-24-998%
-
¥1501.001g常備現(xiàn)貨
-
Bis(perfluorophenyl) 4,7,10,13-tetraoxahexadecane-1,16-dioate
-
BD4688921314378-12-595%
-
¥3428.001g常備現(xiàn)貨
-
Di-tert-butyl 4,7,10,13,16-pentaoxanonadecane-1,19-dioate
-
BD749019439114-12-297%
-
¥590.001g常備現(xiàn)貨
-
3,6,9,12,15,18,21,24,27-Nonaoxanonatriacontan-1-ol
-
BD7489173055-99-099%
-
¥130.0025g常備現(xiàn)貨
-
2,2,3,3-Tetramethyl-4,7,10-trioxa-3-siladodecan-12-ol
-
BD756881201037-95-898%
-
¥251.001g常備現(xiàn)貨
-
3-Oxo-1-phenyl-2,7,10,13,16-pentaoxa-4-azaoctadecan-18-oic acid
-
BD7516121451362-51-897%
-
¥809.001g常備現(xiàn)貨
-
3-(2-(3-Methoxy-3-oxopropoxy)ethoxy)propanoic acid
-
BD7530552089292-48-697%
-
¥2673.001g常備現(xiàn)貨
-
1-Bromo-3,6,9,12-tetraoxapentadecan-15-oic acid
-
BD7589221393330-38-597%
-
¥206.00100mg常備現(xiàn)貨